- Home
- BW vs NKTR Comparison
BW vs NKTR Comparison
Compare BW & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BW
- NKTR
- Stock Information
- Founded
- BW 1867
- NKTR 1990
- Country
- BW United States
- NKTR United States
- Employees
- BW N/A
- NKTR N/A
- Industry
- BW Building Products
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- BW Industrials
- NKTR Health Care
- Exchange
- BW Nasdaq
- NKTR Nasdaq
- Market Cap
- BW 95.7M
- NKTR 108.3M
- IPO Year
- BW N/A
- NKTR 1994
- Fundamental
- Price
- BW $1.31
- NKTR $21.75
- Analyst Decision
- BW Strong Buy
- NKTR Strong Buy
- Analyst Count
- BW 1
- NKTR 6
- Target Price
- BW $5.00
- NKTR $81.67
- AVG Volume (30 Days)
- BW 1.0M
- NKTR 717.4K
- Earning Date
- BW 08-11-2025
- NKTR 08-07-2025
- Dividend Yield
- BW N/A
- NKTR N/A
- EPS Growth
- BW N/A
- NKTR N/A
- EPS
- BW N/A
- NKTR N/A
- Revenue
- BW $734,239,000.00
- NKTR $87,248,000.00
- Revenue This Year
- BW $5.81
- NKTR N/A
- Revenue Next Year
- BW $9.24
- NKTR N/A
- P/E Ratio
- BW N/A
- NKTR N/A
- Revenue Growth
- BW 12.90
- NKTR N/A
- 52 Week Low
- BW $0.22
- NKTR $6.48
- 52 Week High
- BW $2.99
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- BW 68.53
- NKTR 47.41
- Support Level
- BW $0.90
- NKTR $21.02
- Resistance Level
- BW $1.01
- NKTR $23.55
- Average True Range (ATR)
- BW 0.11
- NKTR 1.41
- MACD
- BW 0.03
- NKTR -0.62
- Stochastic Oscillator
- BW 77.07
- NKTR 13.70
About BW Babcock & Wilcox Enterprises Inc.
Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.